Alemtuzumab after natalizumab SWitch in evolving rapidly severe multiple sclerosis (ANSWERS MS): long-term UK & Ireland experience. - Gallagher,P; McGuigan,C; Nicholas,R; Hobart,J; Ford,H; Petheram,K; Sharrack,B; Robertson,N; Mazibrada,G; Scolding,N; Wilson,M; Pearson,O; et al. (SAGE PUBLICATIONS LTD, 2018)